about
Human protein HC and its IgA complex are inhibitors of neutrophil chemotaxisImmunopathology of the lung: a reviewNeutrophil chemotaxis dysfunction in human periodontitis.Serum chemotactic inhibitory activity: heat activation of chemotactic inhibition.Antileukotactic properties of tumor cells.In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel techniqueLeukotaxis and leukotactic disorders. A reviewCharacterization of the protease activity in the chemotactic factor inactivatorAcute inflammation. A review.Regulatory dysfunction in leukotaxisModulation of human eosinophil polymorphonuclear leukocyte migration and functionRestoration by ketoprofen of defective neutrophil granulocyte migration induced in guinea-pigs by plasma from cancer patients.Potentiation of schistosome granuloma formation. By lentinan--a T-cell adjuvantIn vitro and in vivo production of chemotactic inhibitors by tumor cells.Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factorsInhibition of human polymorphonuclear leukocyte chemotaxis by oxygenated sterol compounds.Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization.A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system.Suppression of immune complex-induced inflammation by the chemotactic factor inactivatorChemotactic factor inactivators of human granulocytesPhagocytosis: a review.Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation.The effect of D-penicillamine on polymorphonuclear leukocyte function.Comparison of leukocyte count and function in smoking and nonsmoking young men.Immunological studies of anergic patients.Defective polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis associated with a serum inhibitor.Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action.
P2860
Q24632349-B80A1383-65F0-48D5-878E-CA6A358539FEQ28397007-D07220C8-8402-46B2-AE89-02733B83EA2DQ33897987-6B66BF41-864B-45BC-95EF-50AFAA174A92Q34389731-6D5CBCD9-6089-4BDB-9B7B-B1A6A001F951Q34481379-E04C8D9D-D9D4-4623-A719-18192AC1874EQ34493939-3142E1B7-3542-4481-B16F-756E5E5354B4Q35875620-D876A6BE-5112-43F8-A510-15720826D735Q35902491-DF09F145-BCA2-4386-8982-1C4F4DD5A960Q36076876-383660A1-8923-498A-9F3C-D5BE7C82F10DQ36077739-AA701F92-0A1B-401C-AD22-9045AF14E9B5Q36078173-7F22DB75-66CC-4A20-81BA-DA22896DB8E0Q36091333-DCFC901A-F7C0-494D-B71F-D7721000FEBEQ36092752-09F8EC52-8E9B-43F7-9427-73C55384BCDDQ36092770-EB5BFBC5-19EE-4EE3-A7A3-2CBE9A9E3291Q36341947-14DD7F33-6DCB-4702-A670-5B7226E8AF9FQ36399245-4145808E-8761-4801-964F-461AD7C8E718Q37028014-4BF0A00B-FC18-497E-8818-A84A5C8F7A8FQ37029462-1D8386EA-59F3-4454-8BB3-5B252BC7A210Q37039731-127898B1-F16C-4069-84A0-CEF90141AEF6Q37042134-7C560EEA-0D6B-4C9D-BC9B-497144A5AB70Q37044469-99988AF5-6694-4F23-B57E-ED57C2C9E2DBQ37048897-14E1A3F5-B1B2-4107-AB71-CFBC4698F093Q37811722-2C542EB3-A7E3-4A02-AAC5-793814F74DD6Q40231973-47FD51E2-D78B-40E1-B1F7-B712E84F43CDQ40529301-5D1C20BD-4A5C-4272-860D-B15521E2B5C9Q40881412-A7524D3E-1673-4810-B4A3-AFFB02CEAD0FQ40916219-67D5A316-CC41-42D0-B28F-AABA2F70A3C6Q41115349-4B33BF51-A136-4849-9881-A1E63627606EQ54001850-7A6BF2DC-02D8-40DB-8F30-C3CD48C2C3BC
P2860
description
1973 nî lūn-bûn
@nan
1973 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Chemotactic factor inactivator in normal human serum
@ast
Chemotactic factor inactivator in normal human serum
@en
Chemotactic factor inactivator in normal human serum
@nl
type
label
Chemotactic factor inactivator in normal human serum
@ast
Chemotactic factor inactivator in normal human serum
@en
Chemotactic factor inactivator in normal human serum
@nl
prefLabel
Chemotactic factor inactivator in normal human serum
@ast
Chemotactic factor inactivator in normal human serum
@en
Chemotactic factor inactivator in normal human serum
@nl
P2860
P356
P1476
Chemotactic factor inactivator in normal human serum
@en
P2093
Berenberg JL
P2860
P304
P356
10.1172/JCI107287
P407
P577
1973-05-01T00:00:00Z